XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenues $ 4,977 $ 4,790 $ 9,122 $ 6,797
Cost of Sales 350 5,051 350
Gross Profit (Loss) 4,977 4,440 4,071 6,447
Operating Expenses:        
Sales and Marketing 235,767 35,580 285,498 82,262
Research and Development 116,380 253,317
General and Administrative 756,186 787,427 1,087,131 1,184,820
Total Operating Expenses 1,108,333 823,007 1,625,946 1,267,082
Operating Loss (1,103,356) (818,567) (1,621,875) (1,260,635)
Other Income (Expense)        
Gain on Sale of Asset 482
Gain on Debt Restructuring 516 516
Forgiveness of PPP loan and accrued interest 31,680
Derivative Expense (389,300) (731,500)
Interest Expense (2,118) (140,651) (5,908) (170,873)
Total Other Income (Expense) (2,118) (529,435) 25,772 (901,375)
Net Loss before taxes (1,105,474) (1,348,002) (1,596,103) (2,162,010)
Income Tax Provision
Net Loss $ (1,105,474) $ (1,348,002) $ (1,596,103) $ (2,162,010)
Net Loss Per Share:        
Basic and Diluted $ (0.13) $ (0.23) $ (0.21) $ (0.37)
Weighted Average Common Shares Outstanding:        
Basic and Diluted 8,749,233 5,839,086 7,757,099 5,787,107